Journals / Türk Fertilite Dergisi / 2005 / Cilt: 13 - Sayı: 4

Does activated protein C resistance occur during in vitro fertilization treatment

Kontrollü ovaryen hiperstimulasyon esnasında akkiz APC direnci gelişiyor mu?

Pages
323–327
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: This study demonstrates that despite the considerable changes in endogenous oestradiol and proges­terone levels during an IVF cycle, changes in plasma levels of APC are small and of minor clinical significance.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: In this study, we have investigated whether the hormonal changes induced during in vitro fertilization (IVF) treatment are also associated with acquired APC resistance.
📊
Key Findings & Data:The nAPC did not change significantly during hyperslimulation.
💡
Conclusion & Impact:Conclusion: This study demonstrates that despite the considerable changes in endogenous oestradiol and proges­terone levels during an IVF cycle, changes in plasma levels of APC are small and of minor clinical significance.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: In this study, we have investigated whether the hormonal changes induced during in vitro fertilization (IVF) treatment are also associated with acquired APC resistance. Institution: Department of Obstetrics and Gynecology,. Pamukkale Üniversitesi Medical School, Denizli. Material and Methods: Twenty women, who were planned for an IVF cycle, donated blood at two time points during treatment, i.e. at baseline and hyperstimulation. In the plasma samples, APC sensitivity ratios (nAPC) and the levels of progesterone and estradiol were measured. Results; The changes in plasma concentrations of hor­mones were in accordance with literature. The nAPC did not change significantly during hyperslimulation. The change in estradiol levels between baseline and hyperstim­ulation did not correlate with the change in nAPC. Conclusion: This study demonstrates that despite the considerable changes in endogenous oestradiol and proges­terone levels during an IVF cycle, changes in plasma levels of APC are small and of minor clinical significance.

Özet

Amaç: Tromboz riski hormon tedavileri ile artmaktadır, örneğin doğum kontrol hapları ve postmenapozal hormon tedavisi. Pıhtılaşmanın arttığı diğer bir durumda gebeliktir. Bu üç durumda da tromboz risk artısı kazanılmış aktive pro­tein C (APC) direnci ile beraberdir. Yardımcı üreme tedavi­lerinde de pıhtılaşma artışı ile ilgili komplikasyonları göz­lenmektedir. Biz çalışmamızda kontrollü ovaryan hipersti-mulasyon (KOH)un APC üzerine etkisini inceledik. Çalışmanın Yapıldığı Yer: Pamukkale Üniversitesi Tıp Fakültesi Kadın Hastalıkları ve Doğum Anabilim Dalı, DE­NİZLİ ve Denizli özel Sağlık Tüp Bebek Merkezi Materyal-Metod: Özel Sağlık Hastanesi Tüp Bebek Merkezine başvuran 20 hasta çalışmaya dahil -edildiği hastalarda GnRH analogu île hipoflz baskılanması sonrası rekombinant. FSH ile kontrollü overyan hiperstimulasyon yapılmıştır. İlk kan örneği tedavi öncesinde menstural siklusun 1-3.günleri, ikinci örnek hCG enjeksiyon zamanında alınmıştır. Eş zamanlı alınan serumlarda estradiolve progesteron düzeyleri tespit edilmiştir. Bulgular: Serum estradiol düzeyleri arasında istatistik­sel olarak anlamlı bir farklılık tespit edilmesine (P=.007) rağmen APC oranlan arasında istatistiksel anlamlı farklılık tespit edilmemiştir (P=.O77). Hastaların gerek tedavi öncesi gerek tedavi esnasındaki kan örneklerinde APC direnci tespit edilemedi. Sonuç: Çalışmamızda estrojen düzeylerindeki büyük değişimlere rağmen APC direnci gelişmemiştir. KOH'da akkiz APC direnci gelişmemiştir.

🔖

Cite This Article

BAŞAK, Y., SABUNCUOĞLU, E., TEMUR, İ., ALATAŞ, E., KESKİN, A. (2022). Does activated protein C resistance occur during in vitro fertilization treatment. Türk Fertilite Dergisi, Cilt: 13 - Sayı: 4, 323–327. https://ajindex.com/articles/623336

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. J.P. vandenbroucke, F.M. Helmerhorst. Risk of venous thrombosis with hormone replacement therapy. Lancet 1996
  2. 972 2-U. Kjellberg N.E, Anderson S., Rosen L, Tengborn and M.Hetlgren. APC resistance and other haemostatic variables ­ during pregnmancy and puerperium. Thromb. Haemosl. 1999
  3. J. Rosing, G. Tans. Effects of oral contraceptives on haemostasis and trombosis. Am J Obstet Gynecol. 1999
  4. Bokarewa M, Wramsby M, Breme K. Variability of response to APC during normal pregnancy. Blood Coag Fibrin. 1997:8:239-244. 5-Cumming A. Tail R, Fildes S. Diagnosis of APC resistanceduring pregnancy. Br J HaematoL 1996:92:1026-1027 6-Anne B, Hole K, Oian P. Does ovaryan stimulation for invitro fertilization induce hypercoagulate slate? Hum Reprod, 1991:6:925-27. 6-Castoldi E. Rosing J. Factor V Leiden: a disorder of factormV anticougulant function. Curr Opin Hematol.2004 May
  5. 11(3): 176-81. 7-Ludwig M, Felberbaum RE, Diedrich K. Deep vein thrombo­sis during administration of HMG for ovaryan stimulation. Arch Gynecol Obstet. 2000 Feb
  6. 263(3): 139-41. 8-Horstkamp B, Lubke M, Kentenich H, Riess H, Buscher V, Lichtenegger W. Internal jugular vein thrombosis caused by resis­tance to activated protein C as a complication of ovaryan hyperstimutation after in-vitro fertilization. Hum Reprod. 1996 Feb
  7. 11(2):280-2. 9-Ellis MH, Nun IB, Rathaus V, Werner M, Shenkman L In­ternal jugular vein thrombosis in patients with ovaryan hyperstimulation syndrome. Fertil Steril. 1998 Jan
  8. 69(J): 140-2. 10-Chang FW, Chan CC. Yin CS, Wu GJ. Predicted value of renin activity in a woman who had severe ovaryan hyperstimulation syndrome with internal jugular vein thrombosis. Fertil Steril.2004 Oct
  9. 82(4):937-9. 11-Schanzer A, Rockman CB, Jacobowitz GR, Riles TS. Inter­nal jugular vein thrombosis in association with the ovaryan hyperssimulation syndrome. J Vasc Surg. 2000 Apr
  10. 31(4):815-8. 12-Moutos DM, Miller MM, Mahadevan MM. Prevalence of thrombophilia in women with severe ovaryan hyperstimulation syndrome and cost-effectiveness of screening. Fertil Steril 2004 Apr
  11. 81(4):989-95. 14-Arya R, Shehata HA, Patel RK, Sahu S, Rajasingam D, Harrington KF, Nelson-Piercy C, Parsons JH. Internal jugular vein­ thrombosis after assisted conception therapy. Br J Haematol 2001 Oct
  12. 115(1): 153-5. 15-R.L de Mola, R. Kiwi, C. Austin andJ.M. Goldfarb, Subclavian deep vein thrombosis associated with the use of recombinant follicle-stimulating hormone (gonal-F) complicating mild ovarya